[Dimethyl fumarate (tecfidera) is the first line treatment choice in patients with remitting multiple sclerosis]. [electronic resource]
Producer: 20181101Description: 140-145 p. digitalISSN:- 1997-7298
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.